Increased ceramide concentrations, reduced S1P, decreased phospho-44/42 ERK1/2, and lowered phospho-NF-κB p65 levels contribute to decreased proliferation in cancer cells treated with 7-KSS, potentially facilitating apoptosis. This evidence concerns the gene MAPK3 and cancer.